These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12890536)

  • 1. Microtiter cell-based assay for detection of agents that alter cellular levels of Her2 and EGFR.
    Huezo H; Vilenchik M; Rosen N; Chiosis G
    Chem Biol; 2003 Jul; 10(7):629-34. PubMed ID: 12890536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.
    Zhou H; Kim YS; Peletier A; McCall W; Earp HS; Sartor CI
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):344-52. PubMed ID: 14751502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation, nuclear ploidy, and EGFr and HER2/neu tyrosine kinase oncoproteins in infiltrating ductal breast carcinoma.
    Fernández Val JF; Losada J; Arregui Murua MA; Sarría R
    Cancer Genet Cytogenet; 2002 Oct; 138(1):69-72. PubMed ID: 12419588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
    Kim J; Lee J; Kim C; Choi J; Kim A
    Tumour Biol; 2016 May; 37(5):5811-9. PubMed ID: 26581908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for inducers of kinase degradation.
    Neckers L
    Chem Biol; 2003 Jul; 10(7):587-9. PubMed ID: 12890531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.
    Lu C; Speers C; Zhang Y; Xu X; Hill J; Steinbis E; Celestino J; Shen Q; Kim H; Hilsenbeck S; Mohsin SK; Wakeling A; Osborne CK; Brown PH
    J Natl Cancer Inst; 2003 Dec; 95(24):1825-33. PubMed ID: 14679152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
    Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer.
    Kim ST; Do IG; Lee J; Sohn I; Kim KM; Kang WK
    Clin Transl Oncol; 2015 Jun; 17(6):462-8. PubMed ID: 25445175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer.
    Krähn G; Leiter U; Kaskel P; Udart M; Utikal J; Bezold G; Peter RU
    Eur J Cancer; 2001 Jan; 37(2):251-9. PubMed ID: 11166154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
    Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
    Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes.
    Tanaka-Kagawa T; Hanioka N; Yoshida H; Jinno H; Ando M
    Br J Dermatol; 2003 Dec; 149(6):1116-27. PubMed ID: 14674888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B.
    Kirouac DC; Du J; Lahdenranta J; Onsum MD; Nielsen UB; Schoeberl B; McDonagh CF
    PLoS Comput Biol; 2016 Apr; 12(4):e1004827. PubMed ID: 27035903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients.
    Sassen A; Rochon J; Wild P; Hartmann A; Hofstaedter F; Schwarz S; Brockhoff G
    Breast Cancer Res; 2008; 10(1):R2. PubMed ID: 18182100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.
    Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R
    Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer.
    Jhaveri TZ; Woo J; Shang X; Park BH; Gabrielson E
    Oncotarget; 2015 Jun; 6(17):14754-65. PubMed ID: 26143491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HER2 gene overexpression in breast carcinoma.
    Ménard S; Tagliabue E; Campiglio M; Pupa SM
    J Cell Physiol; 2000 Feb; 182(2):150-62. PubMed ID: 10623878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid screening of drug candidates against EGFR/HER2 signaling pathway using fluorescence assay.
    Khanjani F; Sajedi RH; Hasannia S
    Anal Bioanal Chem; 2018 Dec; 410(30):7827-7835. PubMed ID: 30338368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.